{
    "clinical_study": {
        "@rank": "35130", 
        "acronym": "eperisone", 
        "arm_group": [
            {
                "arm_group_label": "fasting condition", 
                "arm_group_type": "Experimental", 
                "description": "eperisone SR administrated under fasting condition"
            }, 
            {
                "arm_group_label": "Fed condition", 
                "arm_group_type": "Active Comparator", 
                "description": "eperisone SR administrated under fed condition"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the food effect on the pharmacokinetics of\n      eperisone HCl SR tablet"
        }, 
        "brief_title": "Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Low Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "detailed_description": {
            "textblock": "eperisone hydrochloride(muscle relaxant)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy male subjects age between 20 and 55 signed informed consent\n\n        Exclusion Criteria:\n\n          -  Hypotension or hypertension has a history of allergy reaction of this drug or other\n             drugs"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885520", 
            "org_study_id": "NVP-EPT-PK-02"
        }, 
        "intervention": [
            {
                "arm_group_label": "fasting condition", 
                "description": "eperisone SR tablet 75mg administrated under fasting", 
                "intervention_name": "fasting condition", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Fed condition", 
                "description": "eperisone SR tablet 75mg administrated fed condition", 
                "intervention_name": "fed condition", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Eperisone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "low back pain", 
        "lastchanged_date": "June 24, 2013", 
        "location": {
            "contact": {
                "email": "knuhmrc@knu.ac.kr", 
                "last_name": "Yoon Yo Ran, M.D., Ph,D.", 
                "phone": "+82-53-420-5430"
            }, 
            "facility": {
                "address": {
                    "city": "Jung-gu", 
                    "country": "Korea, Republic of", 
                    "state": "Daegu", 
                    "zip": "700-721"
                }, 
                "name": "Kyungpook National University Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized,Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Eperisone HCl SR Tablet 75mg After Oral Administration in Healthy Adult Male Subjects.", 
        "overall_contact": {
            "email": "hjchoi@navipharm.co.kr", 
            "last_name": "Choi H Ju, Scientist", 
            "phone": "+82-31-292-5436"
        }, 
        "overall_official": {
            "affiliation": "Kyungpook National University", 
            "last_name": "Yoon Yo Ran, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "AUC", 
                "safety_issue": "No", 
                "time_frame": "0-24h"
            }, 
            {
                "measure": "Cmax", 
                "safety_issue": "No", 
                "time_frame": "0-24h"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885520"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "T1/2", 
                "safety_issue": "No", 
                "time_frame": "0-24h"
            }, 
            {
                "measure": "Tmax", 
                "safety_issue": "No", 
                "time_frame": "0-24h"
            }
        ], 
        "source": "Navipharm Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Navipharm Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}